Minerva Advisors LLC Increases Stake in Kewaunee Scientific Co. (NASDAQ:KEQU)

Minerva Advisors LLC grew its stake in shares of Kewaunee Scientific Co. (NASDAQ:KEQU) by 4.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 109,493 shares of the technology company’s stock after buying an additional 4,311 shares during the period. Kewaunee Scientific accounts for approximately 3.9% of Minerva Advisors LLC’s portfolio, making the stock its 10th largest holding. Minerva Advisors LLC owned approximately 3.82% of Kewaunee Scientific worth $6,668,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of KEQU. De Lisle Partners LLP increased its position in shares of Kewaunee Scientific by 36.6% during the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after buying an additional 11,511 shares during the period. State Street Corp bought a new stake in shares of Kewaunee Scientific during the third quarter valued at about $266,000. Barclays PLC bought a new stake in shares of Kewaunee Scientific during the third quarter valued at about $121,000. Geode Capital Management LLC increased its position in shares of Kewaunee Scientific by 8.9% during the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after buying an additional 1,941 shares during the period. Finally, JPMorgan Chase & Co. increased its position in shares of Kewaunee Scientific by 18,000.0% in the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after purchasing an additional 900 shares during the last quarter. 32.69% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Kewaunee Scientific news, VP Elizabeth D. Phillips sold 1,850 shares of the stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total transaction of $100,214.50. Following the transaction, the vice president now directly owns 13,591 shares in the company, valued at $736,224.47. This trade represents a 11.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Donald T. Gardner III sold 1,257 shares of the stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $59.26, for a total transaction of $74,489.82. Following the transaction, the chief financial officer now owns 21,358 shares in the company, valued at $1,265,675.08. The trade was a 5.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 11,994 shares of company stock worth $729,430. Insiders own 14.20% of the company’s stock.

Kewaunee Scientific Stock Down 0.7 %

KEQU stock opened at $54.25 on Tuesday. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. The company’s 50 day moving average is $61.05 and its 200 day moving average is $47.73. The stock has a market cap of $155.70 million, a price-to-earnings ratio of 8.60 and a beta of 0.71. Kewaunee Scientific Co. has a 1-year low of $27.00 and a 1-year high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU) last posted its quarterly earnings data on Wednesday, December 11th. The technology company reported $1.41 earnings per share for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Wednesday, December 18th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.